197 related articles for article (PubMed ID: 25900089)
1. Assessment of epithelial sodium channel variants in nonwhite cystic fibrosis patients with non-diagnostic CFTR genotypes.
Brennan ML; Pique LM; Schrijver I
J Cyst Fibros; 2016 Jan; 15(1):52-9. PubMed ID: 25900089
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.
Mutesa L; Azad AK; Verhaeghe C; Segers K; Vanbellinghen JF; Ngendahayo L; Rusingiza EK; Mutwa PR; Rulisa S; Koulischer L; Cassiman JJ; Cuppens H; Bours V
Chest; 2009 May; 135(5):1233-1242. PubMed ID: 19017867
[TBL] [Abstract][Full Text] [Related]
3. Extensive sequence analysis of CFTR, SCNN1A, SCNN1B, SCNN1G and SERPINA1 suggests an oligogenic basis for cystic fibrosis-like phenotypes.
Ramos MD; Trujillano D; Olivar R; Sotillo F; Ossowski S; Manzanares J; Costa J; Gartner S; Oliva C; Quintana E; Gonzalez MI; Vazquez C; Estivill X; Casals T
Clin Genet; 2014 Jul; 86(1):91-5. PubMed ID: 23837941
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of epithelial sodium channel (ENaC) activity in cystic fibrosis cells by epigenetic targeting.
Blaconà G; Raso R; Castellani S; Pierandrei S; Del Porto P; Ferraguti G; Ascenzioni F; Conese M; Lucarelli M
Cell Mol Life Sci; 2022 Apr; 79(5):257. PubMed ID: 35462606
[TBL] [Abstract][Full Text] [Related]
5. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Patterns Correlate with the Expression of
Pierandrei S; Truglio G; Ceci F; Del Porto P; Bruno SM; Castellani S; Conese M; Ascenzioni F; Lucarelli M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916525
[TBL] [Abstract][Full Text] [Related]
7. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
Gianotti A; Melani R; Caci E; Sondo E; Ravazzolo R; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide targeting of mRNAs encoding ENaC subunits α, β, and γ improves cystic fibrosis-like disease in mice.
Zhao C; Crosby J; Lv T; Bai D; Monia BP; Guo S
J Cyst Fibros; 2019 May; 18(3):334-341. PubMed ID: 30100257
[TBL] [Abstract][Full Text] [Related]
9. Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.
Straniero L; Soldà G; Costantino L; Seia M; Melotti P; Colombo C; Asselta R; Duga S
J Hum Genet; 2016 Dec; 61(12):977-984. PubMed ID: 27488443
[TBL] [Abstract][Full Text] [Related]
10. The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis.
Stanke F; Becker T; Cuppens H; Kumar V; Cassiman JJ; Jansen S; Radojkovic D; Siebert B; Yarden J; Ussery DW; Wienker TF; Tümmler B
Hum Genet; 2006 Apr; 119(3):331-43. PubMed ID: 16463024
[TBL] [Abstract][Full Text] [Related]
11. The Epithelial Sodium Channel Is a Modifier of the Long-Term Nonprogressive Phenotype Associated with F508del CFTR Mutations.
Agrawal PB; Wang R; Li HL; Schmitz-Abe K; Simone-Roach C; Chen J; Shi J; Louie T; Sheng S; Towne MC; Brainson CF; Matthay MA; Kim CF; Bamshad M; Emond MJ; Gerard NP; Kleyman TR; Gerard C
Am J Respir Cell Mol Biol; 2017 Dec; 57(6):711-720. PubMed ID: 28708422
[TBL] [Abstract][Full Text] [Related]
12. The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients: Implications for Molecular Diagnostic Testing.
Schrijver I; Pique L; Graham S; Pearl M; Cherry A; Kharrazi M
J Mol Diagn; 2016 Jan; 18(1):39-50. PubMed ID: 26708955
[TBL] [Abstract][Full Text] [Related]
13. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
Wagner CA; Ott M; Klingel K; Beck S; Melzig J; Friedrich B; Wild KN; Bröer S; Moschen I; Albers A; Waldegger S; Tümmler B; Egan ME; Geibel JP; Kandolf R; Lang F
Cell Physiol Biochem; 2001; 11(4):209-18. PubMed ID: 11509829
[TBL] [Abstract][Full Text] [Related]
14. A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition.
Rauh R; Diakov A; Tzschoppe A; Korbmacher J; Azad AK; Cuppens H; Cassiman JJ; Dötsch J; Sticht H; Korbmacher C
J Physiol; 2010 Apr; 588(Pt 8):1211-25. PubMed ID: 20194130
[TBL] [Abstract][Full Text] [Related]
15. Could a defective epithelial sodium channel lead to bronchiectasis.
Fajac I; Viel M; Sublemontier S; Hubert D; Bienvenu T
Respir Res; 2008 May; 9(1):46. PubMed ID: 18507830
[TBL] [Abstract][Full Text] [Related]
16. The CFTR and ENaC debate: how important is ENaC in CF lung disease?
Collawn JF; Lazrak A; Bebok Z; Matalon S
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1141-6. PubMed ID: 22492740
[TBL] [Abstract][Full Text] [Related]
17. New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Giorgetti M; Klymiuk N; Bähr A; Hemmerling M; Jinton L; Tarran R; Malmgren A; Åstrand A; Hansson GC; Ermund A
Eur J Pharmacol; 2021 Aug; 904():174123. PubMed ID: 33974881
[TBL] [Abstract][Full Text] [Related]
18. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
19. Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?
Strandvik B
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800499
[TBL] [Abstract][Full Text] [Related]
20. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
